未名生物医药

Sinobioway Bio-medicine is a prominent Chinese biopharmaceutical company specializing in the development, production, and commercialization of biological products. The company's flagship portfolio includes Enjingfu (Mouse Nerve Growth Factor for injection), which is used to treat nerve damage, and Anferon (Recombinant Human Interferon α2b), utilized for viral infections and oncology. As a key entity within the Peking University Sinobioway Group, it maintains significant manufacturing facilities in Xiamen and Tianjin. The company is listed on the Shenzhen Stock Exchange and has historically held strategic interests in major vaccine manufacturers like Sinovac Biotech. Its business operations focus heavily on infectious diseases, neurology, and high-tech biological manufacturing.